1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Prostatic Disease: new trials by email Literature Review of Prostatic Disease trials Research Report on Prostatic Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC 177Lu-PSMA-617, Ipilimumab, Nivolumab - Prostatic Neoplasms, Genital Neoplasms, Male | Phase 2 | Unknown | Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 93 | 2022-04-29 | 2023-12-15 |
Genital Neoplasms, Male (1) · Neoplasms (1) · Neoplasms by Site (1) · Prostatic Diseases (1) · Prostatic Neoplasms (1) · Urogenital Neoplasms (1)
Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1)
Ipilimumab (1) · Nivolumab (1) · Pluvicto (1)
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (1)
Australia (1)